We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+15.58%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$277M
AUM Growth
-$184M
Cap. Flow
-$202M
Cap. Flow %
-73.1%
Top 10 Hldgs %
50.24%
Holding
173
New
45
Increased
19
Reduced
28
Closed
52

Top Buys

Rank Stock Value
1
VPHM
VIROPHARMA INC
VPHM
+$21.5M
2
SNTS
SANTARUS INC
SNTS
+$11.3M
3
LSI
LSI CORPORATION
LSI
+$10.4M
4
GYRO icon
Gyrodyne
GYRO
+$6.54M
5
RDA
RDA MICROELECTRONICS INC SPONSORED ADR
RDA
+$5.07M

Top Sells

Rank Stock Value
1
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$38.1M
2
NYX
NYSE EURONEXT INC
NYX
+$33.5M
3
DELL
DELL INC
DELL
+$29.1M
4
FIRE
SOURCEFIRE INC COM STK
FIRE
+$15.4M
5
SKS
SAKS INCORPORATED
SKS
+$15M

Sector Composition

Rank Sector Weight
1 Communication Services 9.52%
2 Healthcare 5.72%
3 Technology 5.47%
4 Consumer Discretionary 5.15%
5 Financials 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUNE
101
DELISTED
SUNEDISON, INC COM
SUNE
$183K 0.07%
14,000
-6,000
-30% -$67.7K
MCP
102
DELISTED
MOLYCORP INC COM STK
MCP
$176K 0.06%
31,400
-10,000
-24% -$52.8K
WG
103
DELISTED
Willbros Group
WG
$170K 0.06%
18,000
-3,000
-14% -$27.2K
ELX
104
DELISTED
EMULEX CORP
ELX
$166K 0.06%
23,200
-3,300
-12% -$24.5K
AU icon
105
AngloGold Ashanti
AU
$49.2B
$152K 0.05%
+13,000
New +$177K
YONG
106
DELISTED
YONGYE INTERNATIONAL, INC. COMMON STOCK
YONG
$144K 0.05%
+22,538
New +$143K
CCO icon
107
Clear Channel Outdoor Holdings
CCO
$1.23B
$142K 0.05%
14,000
– –
MWA icon
108
Mueller Water Products
MWA
$4.07B
$94K 0.03%
10,000
-5,000
-33% -$42.6K
EGO icon
109
Eldorado Gold
EGO
$10.2B
$79K 0.03%
+2,786
New +$85.4K
OPCH icon
110
Option Care Health
OPCH
$3.67B
$74K 0.03%
+2,500
New +$70.7K
NEO icon
111
NeoGenomics
NEO
$2.14B
$72K 0.03%
20,000
– –
FST
112
DELISTED
FOREST OIL CORPORATION
FST
$58K 0.02%
+16,100
New +$72.9K
RSOL
113
DELISTED
REAL GOODS SOLAR, INC. CL A COM
RSOL
$45K 0.02%
+15,000
New +$44.2K
RHE
114
DELISTED
Regional Health Properties, Inc.
RHE
$43K 0.02%
833
– –
NIHD
115
DELISTED
NII HOLDINGS INC CL B
NIHD
$43K 0.02%
15,500
-2,500
-14% -$9.21K
LXRX icon
116
Lexicon Pharmaceuticals
LXRX
$1.07B
$27K 0.01%
2,143
– –
GCVRZ
117
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$24K 0.01%
70,170
-820,288
-92% -$991K
BDX icon
118
Becton Dickinson
BDX
$48.9B
– –
-2,460
Closed -$240K
VATE icon
119
INNOVATE Corp
VATE
$97.3M
– –
-5,906
Closed -$200K
VRNT
120
DELISTED
Verint Systems
VRNT
– –
-20,136
Closed -$380K
FOE
121
DELISTED
Ferro Corporation
FOE
– –
-108,965
Closed -$993K
CTB
122
DELISTED
Cooper Tire & Rubber Co.
CTB
– –
-367,088
Closed -$11.3M
AGN
123
DELISTED
Allergan plc
AGN
– –
-2,938
Closed -$423K
S
124
DELISTED
Sprint Corporation
S
– –
-144,932
Closed -$901K
BEL
125
DELISTED
Belmond Ltd.
BEL
– –
-72,388
Closed -$940K
3 4
5
6 7

Similar funds

RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
DPC
Dream Peak Capital Hong Kong $675M AUM
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Gabelli & Co Investment Advisers's Q4 2013 Portfolio in Review

As of Q4 2013, Gabelli & Co Investment Advisers held 173 positions worth $277M, down 40% from $461M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $202M in Q4 2013, closing 52 positions and reducing 28 holdings. Its most notable exit was ONYX PHARMACEUTICALS INC, an estimated $38.1M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 9.5% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Gabelli & Co Investment Advisers opened a new position in VIROPHARMA INC worth $23.9M.

  • Gabelli & Co Investment Advisers's largest Q4 2013 buy was VIROPHARMA INC: 479,941 shares worth $23.9M.
  • Gabelli & Co Investment Advisers added most to Gyrodyne in Q4 2013, an estimated $6.54M increase.
  • Gabelli & Co Investment Advisers's biggest Q4 2013 reduction was Vodafone, cutting an estimated $4.46M.
  • Gabelli & Co Investment Advisers fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $38.1M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 50% of its $277M portfolio in Q4 2013.
  • Gabelli & Co Investment Advisers opened 45 new positions and closed 52 in Q4 2013.
  • Gabelli & Co Investment Advisers's portfolio value fell 40% quarter-over-quarter to $277M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2013, filed 7 Feb 2014.